(29) identified the presence of a specific monocytic signature (MCP-1+, MIP-1ß, TNFα) in a population of untreated SLE patients stimulated with TLR (toll-like receptor) agonists. This evidence concerns the gene CCL2 and systemic lupus erythematosus.